These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8382418)

  • 1. Development of candidate rotavirus vaccines.
    Bishop RF
    Vaccine; 1993; 11(2):247-54. PubMed ID: 8382418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
    Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
    Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials of live oral rotavirus vaccines: the Finnish experience.
    Vesikari T
    Vaccine; 1993; 11(2):255-61. PubMed ID: 8382419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rotaviruses in human and veterinary medicine].
    Dodet B; Heseltine E; Mary C; Saliou P
    Sante; 1997; 7(3):195-9. PubMed ID: 9296811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children.
    Kapikian AZ; Hoshino Y; Chanock RM; Pérez-Schael I
    J Infect Dis; 1996 Sep; 174 Suppl 1():S65-72. PubMed ID: 8752293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination.
    Kapikian AZ; Flores J; Hoshino Y; Glass RI; Midthun K; Gorziglia M; Chanock RM
    J Infect Dis; 1986 May; 153(5):815-22. PubMed ID: 3009632
    [No Abstract]   [Full Text] [Related]  

  • 7. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine.
    Kapikian AZ; Hoshino Y; Chanock RM; Perez-Schael I
    Arch Virol Suppl; 1996; 12():163-75. PubMed ID: 9015113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
    Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen.
    Hoshino Y; Saif LJ; Sereno MM; Chanock RM; Kapikian AZ
    J Virol; 1988 Mar; 62(3):744-8. PubMed ID: 2828669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity.
    Hoshino Y; Jones RW; Chanock RM; Kapikian AZ
    J Med Virol; 1997 Apr; 51(4):319-25. PubMed ID: 9093947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants.
    Clements-Mann ML; Dudas R; Hoshino Y; Nehring P; Sperber E; Wagner M; Stephens I; Karron R; Deforest A; Kapikian AZ
    Vaccine; 2001 Sep; 19(32):4676-84. PubMed ID: 11535316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-rotavirus vaccinations].
    Schmitz J
    Arch Pediatr; 1999 Sep; 6(9):979-84. PubMed ID: 10519034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential.
    Redmond MJ; Ijaz MK; Parker MD; Sabara MI; Dent D; Gibbons E; Babiuk LA
    Vaccine; 1993; 11(2):273-81. PubMed ID: 8382422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus vaccines: an overview.
    Midthun K; Kapikian AZ
    Clin Microbiol Rev; 1996 Jul; 9(3):423-34. PubMed ID: 8809469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model.
    Feng N; Vo PT; Chung D; Vo TV; Hoshino Y; Greenberg HB
    J Infect Dis; 1997 Feb; 175(2):330-41. PubMed ID: 9203654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development.
    Hoshino Y; Kapikian AZ
    J Health Popul Nutr; 2000 Jun; 18(1):5-14. PubMed ID: 11014764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles.
    Herrmann JE; Chen SC; Jones DH; Tinsley-Bown A; Fynan EF; Greenberg HB; Farrar GH
    Virology; 1999 Jun; 259(1):148-53. PubMed ID: 10364499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunity induced by rotavirus DNA vaccines.
    Chen SC; Fynan EF; Robinson HL; Lu S; Greenberg HB; Santoro JC; Herrmann JE
    Vaccine; 1997 Jun; 15(8):899-902. PubMed ID: 9234543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus subunit vaccines.
    Conner ME; Crawford SE; Barone C; O'Neal C; Zhou YJ; Fernandez F; Parwani A; Saif LJ; Cohen J; Estes MK
    Arch Virol Suppl; 1996; 12():199-206. PubMed ID: 9015116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children.
    Kobayashi M; Araki K; Thompson J; Tollefson SJ; Wright PF
    J Infect Dis; 1993 Mar; 167(3):748-52. PubMed ID: 8382725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.